Metraipolis › archive › dc_397b52e49fba

Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications — Europe PMC PMID:41304828

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304828
DOI
10.3390/pharmaceutics17111492
License (as archived)
solo-consultazione
Archived
2026-11-08T10:50:41.786Z
SHA-256 of the archived text
a9a11fd7c6c2b62a9e306e68446958e9fb87eeb807c55893a9b8fbe967cf3872
Stable URL of this page
https://metraipolis.com/documento/dc_397b52e49fba

How to cite

Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications — Europe PMC PMID:41304828 — Europe PMC (en), https://europepmc.org/article/MED/41304828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_397b52e49fba (Metraipolis archive dc_397b52e49fba, sha256 a9a11fd7c6c2b62a9e306e68446958e9fb87eeb807c55893a9b8fbe967cf3872)
BibTeX
@misc{dc397b52e49fba,
  title = {Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications — Europe PMC PMID:41304828},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304828},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_397b52e49fba; sha256 a9a11fd7c6c2b62a9e306e68446958e9fb87eeb807c55893a9b8fbe967cf3872},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304828. Agents can read the archived copy with the MCP tool read_document.